(NASDAQ: NTRA) Natera's forecast annual revenue growth rate of 16.51% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 7.55%, and it is also forecast to beat the US market's average forecast revenue growth rate of 12.67%.
Natera's revenue in 2026 is $2,707,075,000.On average, 27 Wall Street analysts forecast NTRA's revenue for 2026 to be $427,387,464,050, with the lowest NTRA revenue forecast at $406,630,703,570, and the highest NTRA revenue forecast at $449,585,666,230. On average, 27 Wall Street analysts forecast NTRA's revenue for 2027 to be $513,729,821,880, with the lowest NTRA revenue forecast at $461,693,776,510, and the highest NTRA revenue forecast at $573,117,219,920.
In 2028, NTRA is forecast to generate $620,828,940,190 in revenue, with the lowest revenue forecast at $547,747,846,000 and the highest revenue forecast at $732,396,527,770.